Gestational diabetes after delivery: Short-term management and long-term risks

Diabetes Care

Volumn 30, Issue SUPPL. 2, 2007, Pages

  Kitzmiller, John L ^a,d   Dang Kilduff, Leona ^b   Taslimi, M Mark ^c  

^a Santa Clara County Health System   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Santa Clara Valley Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; PIOGLITAZONE;

ARTICLE; CARDIOVASCULAR RISK; ETHNICITY; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; OBESITY; PATIENT CARE; PREGNANCY DIABETES MELLITUS; PUERPERIUM; RISK FACTOR;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES, GESTATIONAL; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; PATIENT EDUCATION AS TOPIC; POSTPARTUM PERIOD; PREGNANCY; RISK FACTORS;

EID: 34447128661     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-s221     Document Type: Article

References (158)

1. Kjos SL: Postpartum care of the woman with diabetes. Clin Obstet Gynecol 43:75-86, 2000
2. Adams KM, Li H, Nelson RL, Ogburn PL Jr, Danilenko-Dixon DR: Sequelae of unrecognized gestational diabetes. Am J Obstet Gynecol 178:1321-1332, 1998
3. Yang X, Hsu-Hage B, Zhang H, Zhang C, Zhang Y, Zhang C: Women with impaired glucose tolerance during pregnancy have significantly poor pregnancy outcomes. Diabetes Care 25:1619-1624, 2002
4. Hedderson MM, Ferrara A, Sacks DA: Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol 102:850-856, 2003
5. Myles TD: An expanded description of delivery-related maternal morbidity for diabetic patients. Obstet Gynecol 101 (Suppl.):38S, 2003
6. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, for the Australian Carbohydrate Intolerance Study in Pregnant Women: Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477-2486, 2005
7. Langer O, Yogev Y, Most O, Xenakis EMJ: Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 192:989-997, 2005
8. Saydah SH, Chandra A, Eberhardt MS: Pregnancy experience among women with and without gestational diabetes in the U.S.: 1995 National Survey of Family Growth. Diabetes Care 28:1035-1040, 2005
9. Kitzmiller JL, Elixhauser A, Carr S, Major CA, De Veciana M, Dang-Kilduff L, Weschler JM: Assessment of costs and benefits of management of gestational diabetes mellitus. Diabetes Care 21 (Suppl. 2):B123-B130, 1998
10. Svarre JA, Hansen BB, Molsted-Pedersen L: Perinatal complications in women with gestational diabetes mellitus: significance of a diagnosis early in pregnancy. Acta Obstet Gynecol Scand 80:899-904, 2001
11. American Dietetic Association: Position of the American Dietetic Association: promoting and supporting breastfeeding. J Am Diet Assoc 105:810-818, 2005
12. Gunderson EP: Breastfeeding after gestational diabetes pregnancy: subsequent obesity and type 2 diabetes in women and their offspring. Diabetes Care 30 (Suppl. 2):S161-S168, 2007
13. Damm P, Mathiesen ER, Petersen KR, Kjos S: Contraception after gestational diabetes. Diabetes Care 30 (Suppl. 2):S236-S241, 2007
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167, 2003
15. Feig DS, Briggs GG, Kraemer JM, Ambrose PJ, Moskovitz DN, Nageotte M, Donat DJ, Padilla G, Wan S, Klein J, Koren G: Transfer of glyburide and glipizide into breast milk. Diabetes Care 28:1851-1855, 2005
16. Hale TW, Kristensen JH, Hackett LP, Kohan R, Ilett KF: Transfer of metformin into human milk. Diabetologia 45:1509-1514, 2002
17. Gardiner SJ, Kirkpatrick CMJ, Begg EJ, Zhang M, Moore MP, Saville DJ: Transfer of metformin into human milk. Clin Pharmacol Ther 73:71-77, 2003
18. Briggs GG, Ambrose PJ, Nageotte MP, Padilla G, Wan S: Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 105:1437-1441, 2005
19. Merlob P, Levitt O, Stahl B: Oral antihyperglycemic agents during pregnancy and lactation. Pediatr Drugs 4:755-760, 2002
20. Creager MA. Luescher TF, Cosentino F, Beckman JA: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 108:1527-1532, 2003
21. Luescher TF, Creager MA, Beckman JA, Cosentino F: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Circulation 108:1655-1661, 2003
22. Conway DL, Langer O: Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol 181:610-614, 1999
23. Ko GTC, Chan JCN, Tsang LWW, Li C-Y, Cockram CS: Glucose tolerance and other cardiovascular risk factors in Chinese women with a history of gestational diabetes. Aust N Z J Obstet Gynecol 39:478-483, 1999
24. Pallardo F, Herranz L, Garcia-Ingelmo T, Grande C, Martin-Vaquero P, Janez M, Gonzalez A: Early postpartum metabolic assessment with prior gestational diabetes. Diabetes Care 22:1053-1058, 1999
25. Costa A, Carmona F, Martinez-Roman S, Quinto L, Levy I, Conget I: Post-partum reclassification of glucose tolerance in women previously diagnosed with gestational diabetes. Diabet Med 17:595-598, 2000
26. Bartha JL, Martinez-del-Fresno P, Comino-Delgado R: Postpartum metabolism and autoantibody markers in women with gestational diabetes mellitus diagnosed in early pregnancy. Am J Obstet Gynecol 184:965-970, 2001
27. Aberg AEB, Jonsson EK, Eskilsson I, Landin-Olsson M, Frid AH: Predictive factors of developing diabetes mellitus in women with gestational diabetes. Acta Obstet Gynecol Scand 81:11-16, 2002
28. Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL: Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 186:751-756, 2002
29. Jang HC, Yim C-H, Han KO, Yoon H-K, Han I-K, Kim M-Y, Yang J-H, Cho NH: Gestational diabetes mellitus in Korea: prevalence and prediction of glucose intolerance at early postpartum. Diabetes Res Clin Pract 61:117-124, 2003
30. Pallardo LF, Herranz L, Martin-Vaquero P, Garcia-Ingelmo T, Grande C, Janez M: Impaired fasting glucose and impaired glucose tolerance in women with prior gestational diabetes are associated with a different cardiovascular profile. Diabetes Care 26:2318-2322, 2003
31. Agarwal MM, Punnose J, Dhatt GS: Gestational diabetes: implications of variation in post-partum follow-up criteria. Eur J Obstet Gynecol Reprod Sci 113:149-153, 2004
32. Winzer C, Pacini G, Tura A, Wagner OF, Waldhausel W, Kautsky-Willer A: Changes in glucose tolerance in women with previous gestational diabetes within one year after delivery: the Viennese Post-Gestational Diabetes Project. Diabetologia 47 (Suppl. 1):A358, 2004
33. Lin CH, Wen SF, Wu YH, Huang YY, Huang MJ: The postpartum metabolic outcome of women with previous gestational diabetes mellitus. Chang Gung Med J 28:794-800, 2005
34. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
35. Alberti KGMM, Zimmet PZ, the WHO Consultation: Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
36. Buchanan TA, Xiang AH, Kjos SL, Trigo E, Lee WP, Peters RK: Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes 48:2430-2436, 1999
37. Kousta E, Lawrence NJ, Penny A, Millauer BA, Robinson S, Dornhorst A, de Swiet M, Steer PJ, Grenfell A, Mather HM, Johnston DG, McCarthy MI: Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes. Diabetes Care 22:933-937, 1999
38. Bian X, Gao P, Xiong X, Xu H, Qian M, Liu S: Risk factors for development of diabetes mellitus in women with a history of gestational diabetes mellitus. Chinese Med J 113:759-762, 2000
39. Linne Y, Barkeling B, Rossner S: Natural course of gestational diabetes mellitus: long-term follow-up of women in the SPAWN study. BJOG 109:1227-1231, 2002
40. Albareda M, Caballero A, Badell G, Piquer S, Ortiz A, de Leiva A, Corcoy R: Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 26:1199-1205, 2003
41. Cypryk K, Czupryniak L, Wilczynski J, Lewinski A: Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose. Acta Diabetol 41:5-8, 2004
42. Lauenborg J, Hansen T, Jensen DM, Vestergaard H, Molsted-Pedersen L, Hornnes P, Locht H, Pedersen O, Damm P: Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 27:1194-1199, 2004
43. Cho NH, Lim S, Jang HC, Park HK, Metzger BE: Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study. Diabetes Care 28:2750-2755, 2005
44. Cheung NW, Helmink D: Gestational diabetes: the significance of persistent fasting hyperglycemia for the subsequent development of diabetes mellitus. J Diabetes Complications 20:21-25, 2006
45. Hunger-Dathe W, Mosebach N, Samann A, Wolf G, Muller UA: Prevalence of impaired glucose tolerance 6 years after gestational diabetes. Exp Clin Endocrinol Diabetes 114:11-17, 2006
46. Lobner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garrido-Franco M, Bonifacio E, Ziegler A-G: Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 55:792-797, 2006
47. Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862-1868, 2002
48. Cheung NW, Byth K: Population health significance of gestational diabetes. Diabetes Care 26:2005-2009, 2003
49. Ben-Haroush A, Yogev Y, Hod M: Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 21:103-113, 2004
50. Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, Ulm M, Streli C, Ludvik B: Pronounced insulin resistance and inadequate betacell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20:1717-1723, 1997
51. Kousta E, Lawrence NJ, Godsland IF, Penny A, Anyaoku V, Millauer BA, Cela E, Johnston DG, Robinson S, McCarthy MI: Insulin resistance and beta-cell dysfunction in normoglycemic European women with a history of gestational diabetes. Clin Endocrinol (Oxf) 59:289-297, 2003
52. Pimenta WP, Calderon IM, Cruz NS, Santos ML, Aragon FF, Padovani CR: Subclinical abnormalities of glucose metabolism in Brazilian women with a history of gestational diabetes mellitus. Acta Obstet Gynecol Scand 83:1152-1158, 2004
53. Catalano PM, Tyzbir ED, Sims EA: Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 13:478-482, 1990
54. Damm P, Kuhl C, Buschard K, Jakobsen BK, Svegaard A, Sodoyez-Goffaux F, Shattock M, Bottazzo GF, Molsted-Pedersen L: Prevalence and predictive value of islet cell antibodies and insulin autoantibodies in women with gestational diabetes. Diabet Med 11:558-563, 1994
55. Beischer NA, Wein P, Sheedy MT, Mackay IR, Rowley MJ, Zimmet P: Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes. Am J Obstet Gynecol 173:1563-1569, 1995
56. Mauricio D, Corcoy R, Codina M, Morales J, Balsells M, de Leiva A: Islet cell antibodies and beta-cell function in gestational diabetic women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects. Diabet Med 12:1009-1014, 1995
57. Fuchtenbusch M, Ferber K, Standl E, Ziegler AG: Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes 46:1459-1467, 1997
58. Jarvela IY, Juutinen J, Koskela P, Hartikainen A-L, Kulmala P, Knip M, Tapanainen JS: Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care 29:607-612, 2006
59. Pan X, Li G, Hu Y, Wang J, Yang W, An Z, Hu Z, Lin J, Xia J, Cao H, Liu P, Jiang X, Jiang Y, Wang J, Zheng H, Zhang H, Bennet P, Howard B: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care 20:537-543, 1997
60. Tuomilehto J, Lindstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1349, 2001
61. Buchanan T, Xiang A, Peters R, Kjos S, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis H, Azen S: Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796-2803, 2002
62. Chiasson J, Josse R, Gomis R, Hanefield M, Karasik A, Laakso M: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 359:2072-2077, 2002
63. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
64. Diabetes Prevention Program (DPP) Research Group: The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 25:2165-2171, 2002
65. Diabetes Prevention Program Research Group: Effects of withdrawal from metformin on the development of diabetes in the Diabetes Prevention Program. Diabetes Care 26:977-980, 2003
66. Xiang AH, Peters RK, Kjos SL, Goico J, Ochoa C, Marroquin A, Tan S, Hodis HN, Azen SP, Buchanan TA: Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function. J Clin Endocrinol Med 89:2846-2851, 2004
67. Diabetes Prevention Program Research Group: Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes 54:1150-1156, 2005
68. Diabetes Prevention Program Research Group: Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care 28:888-894, 2005
69. Diabetes Prevention Program Research Group: Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 54:1566-1572, 2005
70. Diabetes Prevention Program Research Group: Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program: effects of lifestyle intervention and metformin. Diabetes 54:2404-2414, 2005
71. The DREAM (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication) Trial Investigators: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 368:1096-1105, 2006
72. Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Kawakubo M, Buchanan TA: Effect of pioglitazone on pancreatic β-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 55:517-522, 2006
73. Ratner RE: Prevention of type 2 diabetes in women with previous gestation diabetes. Diabetes Care 30 (Suppl. 2):S242-S245, 2007
74. American Diabetes Association and National Institute of Diabetes and Digestive and Kidney Diseases: The prevention or delay of type 2 diabetes (Position Statement). Diabetes Care 25:742-749, 2002
75. Buchanan TA: Prevention of type 2 diabetes: what is it really? Diabetes Care 26:1306-1308, 2003
76. Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG: Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society of Clinical Nutrition. Diabetes Care 27:2067-2073, 2004
77. Tuomilehto J, Wareham N: Glucose lowering and diabetes prevention: are they the same? (Commentary) Lancet 368:1218-1219, 2006
78. Barrett-Connor E, Giardina EG, Gitt A, Gudat U, Steinberg HO, Tschoepe D: Women and heart disease: the role of diabetes and hyperglycemia. Arch Intern Med 164:934-942, 2004
79. Gaede P, Vedel P, Larsen N, Jensen GV, Parving H-H, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393, 2003
80. Towner D, Kjos S, Leung B: Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 11:1446-1451, 1995
81. Schaefer-Graf UM, Buchanan TA, Xiang A: Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 182:313-320, 2000
82. Farrell T, Neale L, Cindy T: Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med 19:322-326, 2002
83. Dunne F, Brydon P, Smith K, Gee H: Pregnancy in women with type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med 20:734-738, 2003
84. Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE: Pre-conception care of diabetes, congenital malformations, and spontaneous abortions (Technical Review). Diabetes Care 19:514-541, 1996
85. MvElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddiqi T, Dignan PS, Tsang RC: A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 9:14-20, 2000
86. Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB: Perinatal mortality in type 2 diabetes mellitus. Diabet Med 17:33-39, 2000
87. Feig D, Palda V: Type 2 diabetes in pregnancy: a growing concern. Lancet 359:1690-1692, 2002
88. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Seikkawa A: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 22:920-924, 1999
89. Davies MJ, Raymond NT, Day JL, Hales CN, Burden AC: Impaired glucose tolerance and fasting hyperglycemia have different characteristics. Diabet Med 17:433-440, 2000
90. DECODE Study Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hr diagnostic criteria. Arch Intern Med 161:397-405, 2001
91. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia [IGT] in humans: role of oxidative stress. Circulation 106:2067-2072, 2002
92. Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T: Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the Risk Factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes Study. Diabetes Care 26:868-874, 2003
93. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY: Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care 26:758-763, 2003
94. Schianca GPC, Rossi A, Sainaghi PP, Maduli E, Bartoli E: The significance of impaired fasting glucose versus impaired glucose tolerance: the importance of insulin secretion and resistance. Diabetes Care 26:1333-1337, 2003
95. Blake DR, Meigs JB, Muller DC, Naijar SS, Andres R, Nathan DM: Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 53:2095-2100, 2004
96. Heldgaard PE, Olivariust NF, Hindsberger C, Henriksen JE: Impaired fasting glycemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, crosssectional study of risk factors for cardiovascular disease. Diabet Med 21:363-370, 2004
97. Tai ES, Goh ES, Lee JJM, Wong M-S, Heng D, Hughes K, Chew SK, Cutter J, Chew W, Gu K, Chia KS, Tan CE: Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care 27:1728-1734, 2004
98. Nichols GA, Brown JB: Higher medical care costs accompany impaired fasting glucose. Diabetes Care 28:2223-2229, 2005
99. Vaccaro O, Riccardi G: Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition. Diabetes Care 28:1786-1788, 2005
100. National Center for Health Statistics and March of Dimes: Peristats. 2002, http://peristats.modimes.org
101. National Institutes of Health, National Heart, Lung and Blood Institute: Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report. Obes Res 6 (Suppl. 2):S51-S210, 1998
102. Janssen I, Katzmarzyk PT, Ross R: Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 162:2074-2079, 2002
103. Snehalatha C, Viswanathan V, Ramachandran A: Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 26:1380-1384, 2003
104. WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157-163, 2004
105. Catalano PM, Vargo KM, Bernstein IM, Amini SB: Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 165:914-919, 1991
106. Metzger BE, Cho NH, Roston SM, Rodvany R: Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes. Diabetes Care 16:1598-1605, 1993
107. Greenberg LR, Moore TR, Murphy H: Gestational diabetes: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 86:97-101, 1995
108. Wein P, Beischer NA, Sheedy MT: Studies of postnatal diabetes mellitus in women who had gestational diabetes. Part 2. Prevalence and predictors of diabetes mellitus after delivery. Aust N Z Obstet Gynecol 37:420-423, 1997
109. Kjos SL, Henry O, Lee RM, Buchanan TA, Mishell DR Jr: The effect of lactation on glucose and lipid metabolism in women with recent gestational diabetes. Obstet Gynecol 82:451-455, 1993
110. McManus RM, Cunningham I, Watson A, Harker L, Finegood DT: Beta-cell function and visceral fat in lactating women with a history of gestational diabetes. Metabolism 50:715-719, 2001
111. Diniz JMM, Da Costa THM: Independent of body adiposity, breast-feeding has a protective effect on glucose metabolism in young adult women. Br J Nutr 92:905-912, 2004
112. Molsted-Pedersen L, Skouby SO, Damm P: Preconception counseling and contraception after gestational diabetes. Diabetes 40 (Suppl. 2):147-150, 1991
113. Petersen KR, Skouby SO, Jespersen J: Contraception guidance in women with pre-existing disturbances in carbohydrate metabolism. Eur J Contracept Reprod Health Care 1:53-59, 1996
114. Kjos SL, Peters RK, Xianh A, Thomas D, Schaefer U, Buchanan TA: Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 280:533-538, 1998
115. Holt RIG, Goddard JR, Clarke P, Coleman MAG: A postnatal fasting plasma glucose is useful in determining which women with gestational diabetes should undergo a postnatal oral glucose tolerance test. Diabet Med 20:594-598, 2003
116. Cundy T, Ducker L, Wrathall K, Morrison J: Agreement between old and new diagnostic criteria in postpartum testing of women with gestational diabetes. Diabetes Care 21:1579-1580, 1998
117. McElduff A, Hitchman R: Fasting plasma glucose values alone miss most abnormalities of glucose tolerance in the postpartum. Diabet Med 21:646-651, 2004
118. Pomerleau J, McKeigue PM, Chaturvedi N: Relationship of fasting and post-load glucose levels to sex and alcohol consumption: are American Diabetes Association criteria biased against detection of diabetes in women? Diabetes Care 22:430-433, 1999
119. Shaw JE, Zimmet PZ, Hodge AM, de Courten M, Dowse GK, Chitson P, Toumilehto J, Alberti KG: Impaired fasting glucose: how low should it go? Diabetes Care 23:34-39, 2000
120. Gomyo M, Sakane N, Kamae I, Sato S, Suzuki K-I, Tominaga M, Kawazu S, Yoshinaga H, Tsushita K, Sato J, Sato Y, Tsujii S, Yoshida T, Seino Y, Usui T, Nanjo K, Hirata M, Kotani K, Hososako A, Kiyohara Y, Kuzuya H: Effects of sex, age and BMI on screening tests for impaired glucose tolerance. Diabetes Res Clin Pract 64:129-136, 2004
121. Hanai K, Kiuchi Y, Wasada T: Prevalence and progression of impaired fasting glucose homeostasis assessed by the different criteria for IFG in Japanese adults. Diabetologia 48:799-800, 2005
122. Padwal R, Majumdar SR, Johnson JA, Varney J, McAlister FA: A systematic review of drug therapy to delay or prevent type 2 diabetes. Diabetes Care 28:736-744, 2005
123. Krentz AJ, Bailey CJ: Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 65:385-341, 2005
124. Kirpichnikov DM, McFarlane SI, Sowers JR: Metformin: an update. Ann Intern Med 137:25-33, 2002
125. St John Sutton M, Rendell M, Dandona P, Dole JF, Murphy K, Patwardhan R, Patel J, Freed M: A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. Diabetes Care 25:2058-2064, 2002
126. Lautamaki R, Airaksinen J, Seppanen M, Toikka J, Luotolahti M, Ball E, Borra R, Harkonene R, Iozza P, Stewart M, Knuuti J, Nuutila P: Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study. Diabetes 54:2787-2794, 2005
127. van Wijk JPH, de Koning EJP, Cabezas MC, Rabelink TJ: Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes. Diabetes Care 28:844-849, 2005
128. Stumvoll M, Tataranni PA, Stefan N, Vozarova B, Bogardus C: Glucose allostasis. Diabetes 52:903-909, 2003
129. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695, 2005
130. Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119, 2005
131. Bergholm R, Tiikkainen M, Vehkavaara S, Tamminen M, Teramo K, Rissanen A, Yki-Jarvinen H: Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilation in obese women with previous gestational diabetes. Diabetes Care 26:1667-1672, 2003
132. Thomas WG: Double trouble for angiotensin receptors in atherosclerosis. N Engl J Med 352:506-508, 2005
133. Johnson FK, Johnson RA, Durante W: Aldosterone promotes endothelial dysfunction via prostacyclin independent of hypertension. Hypertension 46:29-30, 2005
134. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for health-care professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511, 2003
135. Retnarkaran R, Hanley AJG, Raif N, Connelly PW, Sermer M, Zinman B: C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 88:3507-3512, 2003
136. Kjos SL, Buchanan TA, Montoro M, Coulson A, Mestman JH: Serum lipids within 36 months of delivery in women with recent gestational diabetes. Diabetes 40 (Suppl. 2):142-146, 1991
137. Mestman JH: Follow-up studies in women with gestational diabetes mellitus: the experience at Los Angeles County/University of Southern California Medical Center. In Gestational Diabetes. Weiss PAM, Coustan DR, Eds. New York, Springer-Verlag, 1987, p. 191-198
138. Meyers-Seifer CH, Vohr BR: Lipid levels in former gestational diabetic mothers. Diabetes Care 19:1351-1356, 1996
139. Verma A Boney CM, Tucker R, Vohr BR: Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 87:3227-3235, 2002
140. Lauenborg J, Mathiesen E, Hansen T, Glumer C, Jorgensen T, Borch-Johnsen K, Hornnes P, Pedersen O, Damm P: The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 90:4004-4010, 2005
141. Kautzky-Willer A, Krssak M, Winzer C, Pacini G, Tura A, Farhan S, Wagner O, Brabant G, Horn R, Stingl H, Schneider B, Waldhausl W, Roden M: Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 52:244-251, 2003
142. DiBenedetto A, Russo GT, Corrado F, DiCesare E, Alessi E, Nicocia G, D'Anna R, Cucinotta D: Inflammatory markers in women with a recent history of gestational diabetes mellitus. J Endocrinol Invest 28:34-38, 2005
143. Albareda M, Caballero A, Badell G, Rodriguez-Espinosa J, Ordonez-Llanos J, de Leiva A, Corcoy R: Metabolic syndrome at follow-up in women with and without gestational diabetes mellitus in index pregnancy. Metabolism Clin Exper 54:1115-1121, 2005
144. Kautzky-Willer A, Fasching P, Jilma B, Waldhausl W, Wagner OF: Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. J Clin Endocrinol Metab 82:4117-4121, 1997b
145. Sriharan M, Reichelt AJ, Opperman MLR, Duncan BB, Mengue SS, Crook MA, Schmidt MI: Total sialic acid and associated elements of the metabolic syndrome in women with and without previous gestational diabetes. Diabetes Care 25:1331-1335, 2002
146. Di Cianni G, Lencioni C, Volpe L, Ghio A, Cuccuru I, Pellegrini G, Benzi L, Miccoli R, Del Prato S: C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 23:135-140, 2007
147. Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhausl W, Pacini G, Kautzky-Willer A: Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes. Eur J Clin Invest 36:345-352, 2006
148. Heitritter SM, Solomon CG, Mitchell GF, Skali-Ounis N, Seely EW: Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 90:3983-3988, 2005
149. Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D, Pacini G, Funahashi T, Kautsky-Willer A: Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27:1721-1727, 2004
150. Bo S, Monge L, Macchetta C, Menato G, Pinach S, Uberti B, Pagano G: Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome. J Endocrinol Invest 27:629-635, 2004
151. Carpenter MW: Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care 30 (Suppl. 2):S246-S250, 2007
152. Clark HD, van Walraven C, Code C, Karovitch A, Keely E: Did publication of a clinical practice guideline recommendation to screen for type 2 diabetes in women with gestational diabetes change practice? Diabetes Care 26:265-268, 2003
153. Smirnakis KV, Chasan-Taber L, Wolf M, Markenson G, Ecker JL, Thadhani R: Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol 106:1297-1303, 2005
154. Dornhorst A, Frost G: The potential for dietary intervention postpartum in women with gestational diabetes. Diabetes Care 20:1635-1637, 1997
155. Feig DS, Chen E, Naylor CD: Self-perceived health status of women three to five years after the diagnosis of gestational diabetes: a survey of cases and matched controls. Am J Obstet Gynecol 178:386-393, 1998
156. Wein P, Beischer N, Harris C, Permezel M: A trial of simple versus intensified dietary modification for prevention of progression to diabetes mellitus in women with impaired glucose tolerance. Aust N Z J Obstet Gynecol 39:161-165, 1999
157. Stage E, Ronneby H, Damm P: Lifestyle change after gestational diabetes. Diabetes Res Clin Pract 63:67-72, 2004
158. Smith BJ, Cheung NW, Bauman AE, Zehle K, McLean M: Postpartum physical activity and related psychosocial factors among women with recent gestational diabetes mellitus. Diabetes Care 28:2650-2654, 2005